Treatment and rehabilitation of Long COVID: A scope of the literature: Update July 2023

Gary Austin Raine, Claire Louise Khouja, Meena Khatwa, Melissa Harden, Katy Sutcliffe, Amanda Jayne Sowden

Research output: Book/ReportCommissioned report


• We identified 18 randomised controlled trials published since early March 2023 that were focused on Long COVID treatment or rehabilitation. Across our five reports produced to date, we have identified and assessed 73 trials published between January 2022 and June 2023.
• Over half of the trials in the current update had a primary focus on treating persistent problems with the sense of smell or taste (olfactory/gustatory dysfunction)(n=5) or nonspecific Long COVID symptoms (n=5). Other trials focused on fatigue (n=4); pulmonary/respiratory health (n=1); post COVID lung fibrosis (n=1); musculoskeletal
sequelae (n=1); and erectile dysfunction (n=1).
• Five trials were rated positively for at least 11 out of the 13 criteria that we assessed. Four trials met 10 criteria and nine gained a positive rating for between five and nine criteria.
Original languageEnglish
Place of PublicationLondon
PublisherEPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London.
Commissioning bodyNIHR Policy Research Programme
Number of pages25
ISBN (Electronic)978-1-911605-45-4
Publication statusPublished - Jul 2023

Cite this